SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-032917
Filing Date
2024-07-25
Accepted
2024-07-25 08:16:24
Documents
21
Period of Report
2024-07-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20240725.htm   iXBRL 8-K 44048
2 EX-99.1 aqst-selfadministrations.htm EX-99.1 15579
6 aqst-20240725_g1.jpg GRAPHIC 41818
7 aqst-selfadministrations001.jpg GRAPHIC 127804
8 aqst-selfadministrations002.jpg GRAPHIC 136613
9 aqst-selfadministrations003.jpg GRAPHIC 152007
10 aqst-selfadministrations004.jpg GRAPHIC 163154
11 aqst-selfadministrations005.jpg GRAPHIC 168384
12 aqst-selfadministrations006.jpg GRAPHIC 72934
  Complete submission text file 0001628280-24-032917.txt   1427748

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20240725.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20240725_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20240725_pre.xml EX-101.PRE 12504
23 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20240725_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 241139911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)